Skip to results

Keyword or reference number

Decision date

Area of interest

Technology type

Topic selection decision

Type

Showing 21 to 30 of 312

Guidance in topic selection
TitleTechnology typeDecisionDecision date
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]MedicineNot selected
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]MedicineNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]MedicineNot selected
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]MedicineNot selected
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]MedicineNot selected
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]MedicineAwaiting decision
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (review of TA673) [ID6403]MedicineAwaiting decision
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]MedicineAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]MedicineNot selected
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]MedicineNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All